Transdisciplinary Geographic Management Program (GMaP) & Minority Biospecimen/Biobanking Geographic Management Program (BMaP)
GMaP (Transdisciplinary Geographic Management Program) and BMaP (Minority Biospecimen/Biobanking – Geographic Management Program) represent a collaborative group of nine institutions throughout the Southeast (Region 3), funded by the National Cancer Institute, in order to create a state-of-the-art network of dedicated centers for support and management of cancer health disparities research, care, training and infrastructure through a geographic management approach. BMaP works in parallel to GMaP to plan for the creation of the networks/centers by ensuring the adequate and continuous supply of high-quality human biospecimens from multi-ethnic communities for cancer research.
Both GMaP and BMaP have conducted a comprehensive assessment of the resources, activities, research, and education on-going at each institution that is related to health disparities. In Fall 2011, both groups received NCI supplemental funding to pursue two projects:
GMaP is focused on enhancing recruitment to oncology clinical trials by minority patients with cancer;
BMaP is pursuing its examination of the minority population’s views toward participation in biospecimen collection.
GMaP/BMaP Region 3 Network
While there are six GMaP/BMaP regions within the United States, Region 3 consists of Alabama, Georgia, Florida, Mississippi, Louisiana and Puerto Rico. GMaP/BMaP Region 3 has the active involvement of nine institutions. In addition to the Winship Cancer Institute of Emory University, the following sites are participants in our region: UAB Comprehensive Cancer Center, University of Mississippi Health Care, Moffitt Cancer Center, Morehouse School of Medicine, Ponce School of Medicine & Health Sciences, Tulane University, Tuskegee University and Xavier University.
GMaP/BMaP Emory Team